Published in Inflamm Bowel Dis on January 01, 2006
Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC) | NCT02516384
Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol (2010) 2.85
Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy. Clin Gastroenterol Hepatol (2015) 2.64
Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol (2010) 2.10
Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem (2007) 2.06
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol (2007) 1.96
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut (2007) 1.90
Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma. Cell Host Microbe (2010) 1.85
Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol (2006) 1.84
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am J Rhinol (2008) 1.70
Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers (2010) 1.68
Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. J Invest Dermatol (2012) 1.59
The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn's disease patients: a pilot open-labeled prospective study. Int J Colorectal Dis (2012) 1.48
Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases. Dig Dis Sci (2015) 1.45
Tobacco use increases susceptibility to bacterial infection. Tob Induc Dis (2008) 1.45
Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study. Am J Gastroenterol (2016) 1.34
Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun (2008) 1.34
A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol (2010) 1.30
Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS One (2012) 1.28
Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis (2008) 1.28
Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol (2012) 1.26
Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice. Br J Pharmacol (2008) 1.25
Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res (2012) 1.21
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol (2008) 1.19
Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J (2007) 1.19
Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia. Lab Invest (2007) 1.18
Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PLoS One (2012) 1.17
Clonal expansions in ulcerative colitis identify patients with neoplasia. Proc Natl Acad Sci U S A (2009) 1.17
Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem (2010) 1.16
Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflamm Bowel Dis (2010) 1.13
Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease. World J Gastroenterol (2009) 1.12
Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. J Gastrointest Surg (2008) 1.12
The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease. BMC Gastroenterol (2010) 1.10
The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. J Exp Med (2008) 1.10
Anti-Inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model. Infect Immun (2008) 1.06
The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. Inflamm Bowel Dis (2013) 1.05
NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease. J Biol Chem (2013) 1.05
Vedolizumab for the treatment of ulcerative colitis and Crohn's disease. Immunotherapy (2012) 1.04
Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease. Transfus Med Hemother (2007) 1.02
Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration. Clin Nutr (2010) 1.02
Nuclear receptors and inflammatory diseases. Exp Biol Med (Maywood) (2008) 1.01
Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC). BMC Microbiol (2009) 1.01
Using optical markers of nondysplastic rectal epithelial cells to identify patients with ulcerative colitis-associated neoplasia. Inflamm Bowel Dis (2011) 1.01
A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora. Gut (2009) 1.00
Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonist. J Control Release (2008) 0.99
A meta-analysis of antibiotic therapy for active ulcerative colitis. Dig Dis Sci (2007) 0.99
Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center. Inflamm Bowel Dis (2013) 0.98
Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI. Lab Invest (2012) 0.98
TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterol (2009) 0.98
Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study. BMC Gastroenterol (2014) 0.97
Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.95
Preventive and therapeutic euphol treatment attenuates experimental colitis in mice. PLoS One (2011) 0.95
Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis. Dig Dis Sci (2007) 0.95
The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10. Br J Pharmacol (2013) 0.94
Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. Inflamm Bowel Dis (2010) 0.93
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol (2015) 0.93
Trees Assembling Mann-Whitney approach for detecting genome-wide joint association among low-marginal-effect loci. Genet Epidemiol (2012) 0.93
Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor. Free Radic Biol Med (2011) 0.92
Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes. J Pharmacol Exp Ther (2011) 0.92
The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity. J Gastroenterol (2007) 0.91
Acute distal colitis impairs gastric emptying in rats via an extrinsic neuronal reflex pathway involving the pelvic nerve. Gut (2006) 0.91
Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps. Antimicrob Agents Chemother (2012) 0.90
Adverse events in IBD: to stop or continue immune suppressant and biologic treatment. Expert Rev Gastroenterol Hepatol (2014) 0.90
Blowing on embers: commensal microbiota and our immune system. Front Immunol (2014) 0.90
Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis. Am J Physiol Gastrointest Liver Physiol (2009) 0.90
Crohn's disease as an immunodeficiency. Expert Rev Clin Immunol (2010) 0.89
The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS One (2007) 0.89
T cell PPARγ is required for the anti-inflammatory efficacy of abscisic acid against experimental IBD. J Nutr Biochem (2010) 0.89
Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal. Comp Med (2009) 0.89
Effect of exercise on chemically-induced colitis in adiponectin deficient mice. J Inflamm (Lond) (2012) 0.88
Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation. Gut (2007) 0.88
Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol (2008) 0.88
Influence of smoking on colonic gene expression profile in Crohn's disease. PLoS One (2009) 0.88
The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants. PLoS One (2010) 0.88
Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect (2013) 0.88
Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity. Therap Adv Gastroenterol (2013) 0.87
The role of zinc and metallothionein in the dextran sulfate sodium-induced colitis mouse model. Dig Dis Sci (2007) 0.87
SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis. Am J Pathol (2011) 0.86
Advances in nutritional therapy in inflammatory bowel diseases: Review. World J Gastroenterol (2016) 0.86
The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease. Can J Gastroenterol (2012) 0.86
Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study. BMC Gastroenterol (2009) 0.85
Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8, and expression of Toll-like receptor 2 on granulocytes. Dig Dis Sci (2007) 0.85
Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J Inflamm (Lond) (2010) 0.85
Evaluating the Oxidative Stress in Inflammation: Role of Melatonin. Int J Mol Sci (2015) 0.84
Changes of energy metabolism, nutritional status and serum cytokine levels in patients with Crohn's disease after anti-tumor necrosis factor-α therapy. J Clin Biochem Nutr (2013) 0.84
Food allergy among Iranian children with inflammatory bowel disease: A preliminary report. J Res Med Sci (2015) 0.83
A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency. Gastroenterol Hepatol (N Y) (2007) 0.83
Serological markers of inflammatory bowel disease. Biochem Med (Zagreb) (2013) 0.83
Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol (2015) 0.83
Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis. J Clin Biochem Nutr (2010) 0.82
Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases. Dig Dis (2015) 0.82
Inflammatory bowel disease: reviewing an old study under a new perspective. Gut (2007) 0.82
Epidemiology of intrafamilial inflammatory bowel disease throughout Europe. Ann Gastroenterol (2012) 0.82
Second Korean guidelines for the management of Crohn's disease. Intest Res (2017) 0.82
B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease. Dig Dis Sci (2016) 0.81
The prevalence of Crohn's disease in Israel: a 20-year survey. Dig Dis Sci (2008) 0.81
Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus. Sci Rep (2013) 0.81
Dietary uptake of Wedelia chinensis extract attenuates dextran sulfate sodium-induced colitis in mice. PLoS One (2013) 0.81
A meta-analysis of the therapeutic effects of tumor necrosis factor-α blockers on ulcerative colitis. Eur J Clin Pharmacol (2011) 0.81
Increased expression of long pentraxin PTX3 in inflammatory bowel diseases. Dig Dis Sci (2007) 0.81